Research graph
References from Comparative diagnostic utility of cerebrospinal fluid biomarkers in multiple sclerosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Multiple sclerosis: clinical aspects
10.1097/wco.0000000000000622 · 2018 · External reference
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
10.1016/s1474-4422(25)00270-4 · 2025 · External reference
Implementation of the 2024 revision of the McDonald criteria for multiple sclerosis
10.1038/s41582-025-01141-3 · 2025 · External reference
Misdiagnosis of multiple sclerosis: impact of the 2017 McDonald criteria on clinical practice
10.1212/wnl.0000000000006583 · 2019 · External reference
The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study
10.1212/wnl.0000000000003152 · 2016 · External reference
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement
10.1001/archneur.62.6.865 · 2005 · External reference
Cerebrospinal fluid biomarkers in differential diagnosis of multiple sclerosis and systemic inflammatory diseases with central nervous system involvement
10.3390/biomedicines11020425 · 2023 · External reference
The increasing role of kappa free light chains in the diagnosis of multiple sclerosis
10.3390/cells10113056 · 2021 · External reference
Kappa free light chains is a valid tool in the diagnostics of MS: a large multicenter study
10.1177/1352458519845844 · 2020 · External reference
Emerging biomarkers of multiple sclerosis in the blood and the CSF: a focus on neurofilaments and therapeutic considerations
10.3390/ijms23063383 · 2022 · External reference
G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences
10.3758/bf03193146 · 2007 · External reference
Consensus guidelines for lumbar puncture in patients with neurological diseases
10.1016/j.dadm.2017.04.007 · 2017 · External reference
Statistical Package for Social Science. IBM Corp
2012 · External reference
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
2018 · External reference
Misdiagnosis of multiple sclerosis: time for action
10.1177/13524585211005367 · 2021 · External reference
The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis Centre of Catalonia
10.1177/1352458520988148 · 2021 · External reference
Use (and misuse) of the McDonald criteria to diagnose multiple sclerosis
10.1111/ene.13501 · 2018 · External reference
Diagnosis and treatment of multiple sclerosis: a review
10.1001/jama.2020.26858 · 2021 · External reference
Cerebrospinal fluid neurofilament light chains predict early disease activity in multiple sclerosis
10.1016/j.msard.2023.105131 · 2023 · External reference
A comparative study of CSF neurofilament light and heavy chain protein in MS
10.1177/1352458513482374 · 2013 · External reference
Role of chitinase 3-like 1 as a biomarker in multiple sclerosis: a systematic review and meta-analysis
10.1212/nxi.0000000000001164 · 2022 · External reference
Oligoclonal band versus chitinase-3-like protein-1 in CSF of newly diagnosed relapsing-remitting multiple sclerosis
10.55133/eji.300105 · 2023 · External reference
A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: a systematic review and meta-analysis
10.1016/j.msard.2021.102870 · 2021 · External reference
Combined cerebrospinal fluid neurofilament light chain protein and chitinase-3 like-1 levels in defining disease course and prognosis in multiple sclerosis
10.3389/fneur.2019.01008 · 2019 · External reference
